Page last updated: 2024-10-26

diethylcarbamazine and Hepatic Encephalopathy

diethylcarbamazine has been researched along with Hepatic Encephalopathy in 1 studies

Diethylcarbamazine: An anthelmintic used primarily as the citrate in the treatment of filariasis, particularly infestations with Wucheria bancrofti or Loa loa.

Hepatic Encephalopathy: A syndrome characterized by central nervous system dysfunction in association with LIVER FAILURE, including portal-systemic shunts. Clinical features include lethargy and CONFUSION (frequently progressing to COMA); ASTERIXIS; NYSTAGMUS, PATHOLOGIC; brisk oculovestibular reflexes; decorticate and decerebrate posturing; MUSCLE SPASTICITY; and bilateral extensor plantar reflexes (see REFLEX, BABINSKI). ELECTROENCEPHALOGRAPHY may demonstrate triphasic waves. (From Adams et al., Principles of Neurology, 6th ed, pp1117-20; Plum & Posner, Diagnosis of Stupor and Coma, 3rd ed, p222-5)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bjøro, K1
Gjerstad, L1
Bentdal, O1
Osnes, S1
Schrumpf, E1

Other Studies

1 other study available for diethylcarbamazine and Hepatic Encephalopathy

ArticleYear
Topiramate and fulminant liver failure.
    Lancet (London, England), 1998, Oct-03, Volume: 352, Issue:9134

    Topics: Adult; Anticonvulsants; Diethylcarbamazine; Dose-Response Relationship, Drug; Drug Interactions; Fem

1998